Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. (Q54628920)

1 June 2018

title

Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. (English)

1 reference

1 June 2018

1 reference

1 reference

1 reference

Wolcott DL

1

1 reference

1 June 2018

Marsh JT

2

1 reference

1 June 2018

La Rue A

3

1 reference

1 June 2018

Carr C

4

1 reference

1 June 2018

Nissenson AR

5

1 reference

1 June 2018

publication date

1 December 1989

1 reference

1 June 2018

American Journal of Kidney Diseases

published in

1 reference

1 June 2018

volume

14

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

478-485

1 reference

1 June 2018

Anemia of end-stage renal disease (ESRD).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

The quality of life of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Physical activity and employment status of patients on maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

End-stage renal disease treatment modality and patients' quality of life. Longitudinal assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Neuropsychological patterns in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Intellectual functioning in renal failure and chronic dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Effects of hemodialysis on the cognitive and sensory-motor functioning of the adult chronic hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Quantitative indices of clinical uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Electrophysiological indices of CNS function in hemodialysis and CAPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Working capacity is increased following recombinant human erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Recombinant human erythropoietin: implications for nephrology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Quality of life in chronic dialysis patients: a critical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Temporal effects of hemodialysis on measures of neural efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980148-9

7 January 2021

10.1016/S0272-6386(89)80148-9

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018